Wednesday, June 19, 2019
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Food and Drug Administration has provided 510(k) market clearance for the PROLIFT Lateral Expandable Spacer System.
“The PROLIFT Lateral Expandable Spacer System is a significant addition to Life Spine’s rapidly growing expandable portfolio. The device will be available in a multitude of footprints and lordotic options, allows for post-packing in situ, has anatomically convex endplates and has Life Spine’s proprietary OSSEO-LOC™ surface technology,” said Rich Mueller, COO of Life Spine.
The system features minimal insertion height and controlled, in situ expansion which are critical components in a MIS Expandable Lateral Interbody Fusion. The PROLIFT Lateral is complemented by Life Spine’s full lateral portfolio which consists of the CENTRIC® Retractor, Lateral Disc Prep, OSTEO-LINE® Graft Delivery Device, Neuromonitoring Instruments, LONGBOW® Expandable Spacer System and the SENTRY® Lateral Plating Systems.
